(2R,3S,4S,5R,6S)-2-(HYDROXYMETHYL)-6-((5-ISOPROPYL-4-(2-METHYL-4-(3-(NEOPENTYLAMINO)PROPOXY)BENZYL)-1H-PYRAZOL-3-YL)OXY)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL
UNII 0T6DZ14EWQ
Substance Identification & Data
This profile provides standardized clinical and technical data for (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-((5-isopropyl-4-(2-methyl-4-(3-(neopentylamino)propoxy)benzyl)-1h-pyrazol-3-yl)oxy)tetrahydro-2h-pyran-3,4,5-triol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0T6DZ14EWQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H45N3O7 BYERKRNJPABGHF-FOORKGQUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-((5-isopropyl-4-(2-methyl-4-(3-(neopentylamino)propoxy)benzyl)-1h-pyrazol-3-yl)oxy)tetrahydro-2h-pyran-3,4,5-triol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.